-
Amisulpride, sold
under the
brand names Solian and Barhemsys, is a
medication used in the
treatment of schizophrenia,
acute psychotic episodes, depression...
- A
comparison to
amisulpride published in 2022,
found that
aripiprazole was
effective in
treating negative symptoms,
while amisulpride was not.[non-primary...
- SEP-4199, also
known as non-racemic
amisulpride, is a non-racemic form of
amisulpride which is
under development for the
treatment of
bipolar depression...
- 400 mg/day
amisulpride achieved around 70%
occupancy and
doses of 630 to 910 mg/day
amisulpride achieved 70 to 80%
occupancy of the receptor.
Amisulpride has...
-
functionally similar to
other benzamide antipsychotics such as
sulpiride and
amisulpride known for
their dopamine antagonist effects.
Research in
animal models...
- and mild depression. The drug is
chemically and
clinically similar to
amisulpride.
Levosulpiride is its
purified levo-isomer and is sold in some countries...
-
irreversible inhibitor of MAO-B, and weak NRI
Atypical antipsychotics include:
Amisulpride (Solian) –
approved in low
doses as a
monotherapy for
persistent depression...
- thiothixene, and trifluoperazine, the
atypical antipsychotics such as
amisulpride, clozapine, olanzapine,
quetiapine (Seroquel),
risperidone (Risperdal)...
-
levorotatory enantiomer of sulpiride.
Other benzamide derivatives include amisulpride, metoclopramide, tiapride, sultopride, and veralipride,
among others...
- to
affect prolactin levels when
compared to
typical antipsychotics.
Amisulpride binds D2 and D3 and is used as an antipsychotic,
antidepressant and also...
